313 related articles for article (PubMed ID: 27903984)
21. New Concept of X-Ray Repair Cross-Complementing Groups 1 Polymorphisms and Gynecologic Cancer Risk.
Du Y; Wang H; Lv B
Gynecol Obstet Invest; 2018; 83(1):15-22. PubMed ID: 28391259
[TBL] [Abstract][Full Text] [Related]
22. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and gastric cancer risk: A HuGE review and meta-analysis.
Xue H; Ni P; Lin B; Xu H; Huang G
Am J Epidemiol; 2011 Feb; 173(4):363-75. PubMed ID: 21216841
[TBL] [Abstract][Full Text] [Related]
23. XRCC1 Gene Polymorphisms and Breast Cancer Risk: A Systematic Review and Meta- Analysis Study.
Sanjari Moghaddam A; Nazarzadeh M; Sanjari Moghaddam H; Bidel Z; Keramatinia A; Darvish H; Mosavi-Jarrahi A
Asian Pac J Cancer Prev; 2016; 17(S3):323-30. PubMed ID: 27165246
[TBL] [Abstract][Full Text] [Related]
24. Association between the XRCC1 Arg399Gln polymorphism and risk of cervical carcinoma: a meta-analysis.
Liu DY; Liang HC; Xiao XM
Genet Mol Res; 2015 Aug; 14(3):9821-8. PubMed ID: 26345915
[TBL] [Abstract][Full Text] [Related]
25. Association between XRCC1 gene polymorphisms and risk of glioma development: a meta-analysis.
Sun JY; Zhang CY; Zhang ZJ; Dong YF; Zhang AL; Wang ZW; Mei XL
Asian Pac J Cancer Prev; 2012; 13(9):4783-8. PubMed ID: 23167420
[TBL] [Abstract][Full Text] [Related]
26. XRCC1 polymorphisms increase bladder cancer risk in Asians: a meta-analysis.
Zhang F; Wu JH; Zhao W; Liu HT
Tumour Biol; 2013 Oct; 34(5):2659-64. PubMed ID: 23636799
[TBL] [Abstract][Full Text] [Related]
27. XRCC1 Arg194Trp and Arg280His polymorphisms increase bladder cancer risk in Asian population: evidence from a meta-analysis.
Fang Z; Chen F; Wang X; Yi S; Chen W; Ye G
PLoS One; 2013; 8(5):e64001. PubMed ID: 23704969
[TBL] [Abstract][Full Text] [Related]
28. The XRCC1 Arg194Trp polymorphism was associated with the risk of head and neck squamous cell carcinoma development: Results from a systematic review and meta-analysis.
Mohtasham N; Najafi-Ghobadi K; Abbaszadeh H
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1776. PubMed ID: 36573562
[TBL] [Abstract][Full Text] [Related]
29. The XRCC1 Arg194Trp and Arg280His polymorphisms in head and neck cancer susceptibility: a meta-analysis.
Zhou X; Gu L; Zeng Y; Wei L; Ying M; Wang N; Su C; Wang Y; Liu C
Tumour Biol; 2014 Nov; 35(11):10665-76. PubMed ID: 25062722
[TBL] [Abstract][Full Text] [Related]
30. Association between X-Ray Repair Cross-Complementing Group 1 Arg399Gln Polymorphism and Cervical Cancer Risk: A Meta-Analysis in the Chinese Population.
Zhang F; Li B; Wu HY; Shang LX
Gynecol Obstet Invest; 2017; 82(4):382-387. PubMed ID: 27487002
[TBL] [Abstract][Full Text] [Related]
31. X-ray repair cross-complementing group 1(XRCC1) genetic polymorphisms and thyroid carcinoma risk: a meta-analysis.
Qian K; Liu KJ; Xu F; Chen XY; Chen GN; Yi WJ; Zhou EX; Tang ZH
Asian Pac J Cancer Prev; 2012; 13(12):6385-90. PubMed ID: 23464463
[TBL] [Abstract][Full Text] [Related]
32. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis.
Wang L; Yin F; Xu X; Hu X; Zhao D
PLoS One; 2012; 7(4):e34897. PubMed ID: 22529951
[TBL] [Abstract][Full Text] [Related]
33. Associations between XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms and risk of differentiated thyroid carcinoma: a meta-analysis.
Du Y; Han LY; Li DD; Liu H; Gao YH; Sun DJ
Asian Pac J Cancer Prev; 2013; 14(9):5483-7. PubMed ID: 24175846
[TBL] [Abstract][Full Text] [Related]
34. XRCC1 Arg194Trp polymorphism and thyroid cancer.
Liu SY; Xue W
J Endocrinol Invest; 2020 Jun; 43(6):749-753. PubMed ID: 31820401
[TBL] [Abstract][Full Text] [Related]
35. XRCC1 polymorphisms and cervical cancer risk: an updated meta-analysis.
Mei J; Duan HX; Wang LL; Yang S; Lu JQ; Shi TY; Zhao Y
Tumour Biol; 2014 Feb; 35(2):1221-31. PubMed ID: 24057881
[TBL] [Abstract][Full Text] [Related]
36. Genetic polymorphisms of XRCC1 and leukemia risk: a meta-analysis of 19 case-control studies.
Zhang H; Liu H; Jiang G
PLoS One; 2013; 8(11):e80687. PubMed ID: 24363792
[TBL] [Abstract][Full Text] [Related]
37. Association between the XRCC1 polymorphisms and thyroid cancer risk: a meta-analysis from case-control studies.
Wu FF; He XF; Shen HW; Qin GJ
PLoS One; 2014; 9(9):e87764. PubMed ID: 25211472
[TBL] [Abstract][Full Text] [Related]
38. Meta-Analysis of the Relationship between XRCC1-Arg399Gln and Arg280His Polymorphisms and the Risk of Prostate Cancer.
Yan J; Wang X; Tao H; Deng Z; Yang W; Lin F
Sci Rep; 2015 Apr; 5():9905. PubMed ID: 25927275
[TBL] [Abstract][Full Text] [Related]
39. XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis.
Wang B; Wang D; Huang G; Zhang C; Xu DH; Zhou W
Int J Colorectal Dis; 2010 Mar; 25(3):313-21. PubMed ID: 20033188
[TBL] [Abstract][Full Text] [Related]
40. XRCC1 genetic polymorphism Arg339Gln, Arg194Trp, Arg280His and gastric cancer risk: an evidence based decision.
Zhao DY; Cheng L; Yu J; Shen H
Cancer Biomark; 2014; 14(6):449-56. PubMed ID: 25335737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
